HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.705

-0.045-0.78%

Volume:5.20M

Turnover:29.86M

Market Cap:9.11B

PE:-18.13

High:5.860

Open:5.750

Low:5.600

Close:5.750

52wk High:13.150

52wk Low:4.010

Shares:1.60B

HK Float Shares:1.60B

Volume Ratio:0.54

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.315

ROE:-52.14%

ROA:-14.44%

PB:6.04

PE(LYR):-18.13

PS:18.36

Loading ...

Overview Company News Filings

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses

Simply Wall St.

Stock Track | CStone Pharma-B Soars 5.04% Intraday on Bullish Analyst Reports and Positive CS2009 Clinical Data

Two Major Foreign Institutions Bullish on CStone Pharma: Peak Target Price Set at HK$20, CS2009 Emerges as Key Catalyst

CStone Pharmaceuticals' Loss Widens in 2025

MT Newswires Live

CStone Pharmaceuticals-B Surges Over 20% by Late Morning on Strong CS2009 Lung Cancer Efficacy Data

CSTONE PHARMA-B (02616) Surges Over 20% on Strong CS2009 Lung Cancer Efficacy Data; First Phase III Global Trials Expected This Year

Stock Track | CStone Pharma Soars 5.51% Intraday on Strong 2025 Results and Promising Pipeline Progress

Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0

CStone Pharmaceuticals - Loss for the Year Was RMB437.0 Million

THOMSON REUTERS

CStone Pharmaceuticals FY2025; revenue drops 33.8% to RMB 270 million due to lower licensing fees

CStone reports 90% ORR in first-line NSCLC for trispecific antibody CS2009; Phase III global trials slated for 2026

Bulletin Express

CStone Pharmaceuticals-B Unveils Latest Clinical Progress and Phase I/II Key Data for Trispecific Antibody CS2009

CStone Pharmaceuticals reports CS2009 Phase I safety; Grade ≥3 TRAEs rise to 23%

CStone Pharmaceuticals reports CS2009 Phase I/II progress; ORR rises to 90% in first-line NSCLC with PD-L1 TPS≥50%

CSTONE PHARMA-B Shares Extend Gains Following Top ESMO Guideline Recommendation for Core Product

CStone Pharmaceuticals' Sugemalimab Receives ESMO Guideline Recommendation for Stage III NSCLC Consolidation Therapy

CStone Pharmaceuticals’ sugemalimab gains ESMO I,A recommendation; consolidation treatment duration rises to 24 months for stage III NSCLC

CSTONE PHARMA-B Shares Climb Over 4% on Triple Pipeline Recognition at Prestigious Cancer Conference

CSTONE PHARMA-B to Present Three Self-Developed Pipeline Findings at Prestigious Global Oncology Conference

CStone Pharma-B (02616 HK) to Showcase Three Novel ADC Candidates at AACR 2026

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02616/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02616","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","market":"HK","secType":"STK","nameCN":"CSTONE PHARMA-B","latestPrice":5.705,"timestamp":1788250093007,"preClose":5.75,"halted":0,"volume":5200000,"delay":0,"changeRate":-0.007826086956521728,"floatShares":1596000000,"shares":1596000000,"eps":-0.314752,"marketStatus":"Closed","change":-0.045,"latestTime":"09-01 16:08:13","open":5.75,"high":5.86,"low":5.6,"amount":29861363,"amplitude":0.045217,"askPrice":5.705,"askSize":87000,"bidPrice":5.675,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.302,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788312600000},"marketStatusCode":5,"adr":0,"listingDate":1551110400000,"exchange":"SEHK","adjPreClose":5.75,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.54491,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02616\",,,,,undefined,":{"symbol":"02616","floatShares":1596000000,"roa":"-14.44%","roe":"-52.14%","lyrEps":-0.314752,"volumeRatio":0.54491,"shares":1596000000,"dividePrice":0,"high":5.86,"amplitude":0.045217,"preClose":5.75,"low":5.6,"week52Low":4.01,"pbRate":"6.04","psRate":"18.36","week52High":13.15,"institutionHeld":0,"latestPrice":5.705,"committee":-0.933333,"eps":-0.314752,"divideRate":0,"volume":5200000,"delay":0,"ttmEps":-0.302,"open":5.75,"prevYearClose":5.27,"prevWeekClose":5.89,"prevMonthClose":5.75,"prevQuarterClose":4.71,"fiveDayClose":5.84,"twentyDayClose":4.525,"sixtyDayClose":4.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02616\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-26","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-08-14","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755135000000,"name":null,"time":"","dateTimestamp":1755100800000,"actualEps":null},{"date":"2025-03-27","symbol":"02616","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"Pre-MKt","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-23","symbol":"02616","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724376600000,"name":null,"time":"","dateTimestamp":1724342400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02616\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02616\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1775145600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02616\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02616","date":"2026-08-31","current":-18.890728,"percent":0.280098,"low":-136.537801,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"high":-1.28563,"avg":-13.929462,"sd":18.343813,"marketCap":9166145891},"quantilePoints":[{"date":"2021-09-03","current":-10.209714,"twenty":-11.257766,"median":-8.052957,"eighty":-5.355236,"marketCap":16269404808},{"date":"2021-09-10","current":-9.343346,"twenty":-11.210508,"median":-8.185359,"eighty":-5.364215,"marketCap":14927121054},{"date":"2021-09-17","current":-8.949727,"twenty":-11.20047,"median":-8.434657,"eighty":-5.3787,"marketCap":14255979177},{"date":"2021-09-24","current":-8.234007,"twenty":-11.19935,"median":-8.434657,"eighty":-5.380222,"marketCap":13121980833},{"date":"2021-09-30","current":-7.839337,"twenty":-11.192661,"median":-8.399615,"eighty":-5.382695,"marketCap":12534829867},{"date":"2021-10-08","current":-7.345169,"twenty":-11.111271,"median":-8.201573,"eighty":-5.38891,"marketCap":11744135590},{"date":"2021-10-15","current":-7.158447,"twenty":-11.047167,"median":-8.13024,"eighty":-5.402482,"marketCap":11453439164},{"date":"2021-10-22","current":-7.107419,"twenty":-11.021608,"median":-8.052957,"eighty":-5.419451,"marketCap":11453439164},{"date":"2021-10-29","current":-6.9876,"twenty":-10.913219,"median":-7.905378,"eighty":-5.424788,"marketCap":11232509881},{"date":"2021-11-05","current":-6.521477,"twenty":-10.751223,"median":-7.736229,"eighty":-5.429889,"marketCap":10500496508},{"date":"2021-11-12","current":-6.911857,"twenty":-10.72568,"median":-7.556243,"eighty":-5.439163,"marketCap":11174947004},{"date":"2021-11-19","current":-7.562679,"twenty":-10.701803,"median":-7.433682,"eighty":-5.461865,"marketCap":12209879661},{"date":"2021-11-26","current":-7.617861,"twenty":-10.663803,"median":-7.561565,"eighty":-5.484543,"marketCap":12302907315},{"date":"2021-12-03","current":-7.259305,"twenty":-10.643156,"median":-7.468211,"eighty":-5.498458,"marketCap":11745511604},{"date":"2021-12-10","current":-6.694442,"twenty":-10.638167,"median":-7.415818,"eighty":-5.502206,"marketCap":10850061709},{"date":"2021-12-17","current":-6.016959,"twenty":-10.577662,"median":-7.345169,"eighty":-5.508139,"marketCap":9745285865},{"date":"2021-12-24","current":-6.061431,"twenty":-10.471572,"median":-7.288494,"eighty":-5.512987,"marketCap":9826690401},{"date":"2021-12-31","current":-5.927226,"twenty":-10.433659,"median":-7.259398,"eighty":-5.512973,"marketCap":9630021066},{"date":"2022-01-07","current":-5.24476,"twenty":-5.885319,"median":-5.561747,"eighty":-5.274171,"marketCap":8488857748},{"date":"2022-01-14","current":-5.434369,"twenty":-5.739435,"median":-5.400163,"eighty":-5.320351,"marketCap":8814904410},{"date":"2022-01-21","current":-5.350332,"twenty":-5.667482,"median":-5.495343,"eighty":-5.345425,"marketCap":8698459174},{"date":"2022-01-28","current":-4.179198,"twenty":-5.655726,"median":-5.359716,"eighty":-5.156862,"marketCap":6777112770},{"date":"2022-02-04","current":-4.314568,"twenty":-5.65234,"median":-5.352863,"eighty":-4.82542,"marketCap":6993202476},{"date":"2022-02-11","current":-4.305871,"twenty":-5.588386,"median":-5.338065,"eighty":-4.357596,"marketCap":6993202476},{"date":"2022-02-18","current":-4.549058,"twenty":-5.561747,"median":-5.217261,"eighty":-4.357596,"marketCap":7424449962},{"date":"2022-02-25","current":-4.580613,"twenty":-5.541925,"median":-4.82542,"eighty":-4.340347,"marketCap":7494381986},{"date":"2022-03-04","current":-4.265532,"twenty":-5.495343,"median":-4.615232,"eighty":-4.340347,"marketCap":6981547138},{"date":"2022-03-11","current":-3.829807,"twenty":-5.434369,"median":-4.592981,"eighty":-4.305871,"marketCap":6258916216},{"date":"2022-03-18","current":-3.70909,"twenty":-5.365958,"median":-4.554202,"eighty":-4.254145,"marketCap":6037464804},{"date":"2022-03-25","current":-4.009659,"twenty":-5.353473,"median":-4.514341,"eighty":-4.051774,"marketCap":6526988977},{"date":"2022-04-01","current":-3.604513,"twenty":-5.352254,"median":-4.446056,"eighty":-3.939197,"marketCap":5874464342},{"date":"2022-04-08","current":-3.602952,"twenty":-5.350716,"median":-4.358449,"eighty":-3.856607,"marketCap":5874464342},{"date":"2022-04-14","current":-3.608921,"twenty":-5.342972,"median":-4.33861,"eighty":-3.719598,"marketCap":5874464342},{"date":"2022-04-22","current":-3.677661,"twenty":-5.320351,"median":-4.323136,"eighty":-3.639031,"marketCap":5874464342},{"date":"2022-04-29","current":-3.73782,"twenty":-5.274171,"median":-4.305768,"eighty":-3.660706,"marketCap":5874464342},{"date":"2022-05-06","current":-3.769129,"twenty":-5.23376,"median":-4.265532,"eighty":-3.683855,"marketCap":5874464342},{"date":"2022-05-13","current":-3.837797,"twenty":-5.189762,"median":-4.179198,"eighty":-3.708631,"marketCap":5874464342},{"date":"2022-05-20","current":-3.784694,"twenty":-5.107513,"median":-4.086461,"eighty":-3.70909,"marketCap":5874464342},{"date":"2022-05-27","current":-3.78798,"twenty":-4.82542,"median":-4.009659,"eighty":-3.709727,"marketCap":5874464342},{"date":"2022-06-02","current":-3.812613,"twenty":-4.725127,"median":-3.992083,"eighty":-3.710569,"marketCap":5944398442},{"date":"2022-06-10","current":-2.879454,"twenty":-4.638595,"median":-3.924041,"eighty":-3.708998,"marketCap":6468904187},{"date":"2022-06-17","current":-2.534624,"twenty":-4.610433,"median":-3.837797,"eighty":-3.629407,"marketCap":5687973411},{"date":"2022-06-24","current":-2.91257,"twenty":-4.600342,"median":-3.834186,"eighty":-3.605183,"marketCap":6562149652},{"date":"2022-06-30","current":-2.7397,"twenty":-4.595236,"median":-3.824248,"eighty":-3.603889,"marketCap":6162036300},{"date":"2022-07-08","current":-2.789013,"twenty":-4.58556,"median":-3.810066,"eighty":-3.585543,"marketCap":6279408420},{"date":"2022-07-15","current":-2.657247,"twenty":-4.567853,"median":-3.804578,"eighty":-3.040197,"marketCap":5927292060},{"date":"2022-07-22","current":-2.439909,"twenty":-4.553174,"median":-3.796104,"eighty":-2.88352,"marketCap":5446066368},{"date":"2022-07-29","current":-2.179587,"twenty":-4.54278,"median":-3.786337,"eighty":-2.825625,"marketCap":4870942980},{"date":"2022-08-05","current":-2.179915,"twenty":-4.524043,"median":-3.773711,"eighty":-2.777759,"marketCap":4859266866},{"date":"2022-08-12","current":-2.113849,"twenty":-4.48743,"median":-3.764949,"eighty":-2.726876,"marketCap":4718418551},{"date":"2022-08-19","current":-2.12991,"twenty":-4.458004,"median":-3.759652,"eighty":-2.661134,"marketCap":4706681191},{"date":"2022-08-26","current":-2.634132,"twenty":-4.445198,"median":-3.737568,"eighty":-2.601682,"marketCap":5774780913},{"date":"2022-09-02","current":-2.482455,"twenty":-4.392287,"median":-3.726604,"eighty":-2.570557,"marketCap":5422721701},{"date":"2022-09-09","current":-2.357096,"twenty":-4.358278,"median":-3.709409,"eighty":-2.530744,"marketCap":5129284379},{"date":"2022-09-16","current":-2.422633,"twenty":-4.350696,"median":-3.693146,"eighty":-2.492961,"marketCap":5223184322},{"date":"2022-09-23","current":-2.643578,"twenty":-4.338957,"median":-3.632117,"eighty":-2.424059,"marketCap":4389822329},{"date":"2022-09-30","current":-2.491968,"twenty":-4.334804,"median":-3.607643,"eighty":-2.431682,"marketCap":4145970216},{"date":"2022-10-07","current":-2.435149,"twenty":-4.328276,"median":-3.604942,"eighty":-2.427988,"marketCap":4051205182},{"date":"2022-10-14","current":-2.569205,"twenty":-4.312829,"median":-3.604513,"eighty":-2.427988,"marketCap":4228889620},{"date":"2022-10-21","current":-2.789816,"twenty":-4.30585,"median":-3.6011,"eighty":-2.436101,"marketCap":4560567238},{"date":"2022-10-28","current":-2.620394,"twenty":-4.30145,"median":-3.574811,"eighty":-2.447476,"marketCap":4276272137},{"date":"2022-11-04","current":-2.801766,"twenty":-4.280449,"median":-3.186067,"eighty":-2.475622,"marketCap":4616748608},{"date":"2022-11-11","current":-2.534296,"twenty":-4.263255,"median":-2.894354,"eighty":-2.478687,"marketCap":4213228164},{"date":"2022-11-18","current":-2.700603,"twenty":-4.239156,"median":-2.889868,"eighty":-2.483082,"marketCap":4474329627},{"date":"2022-11-25","current":-2.418931,"twenty":-4.177717,"median":-2.865074,"eighty":-2.475622,"marketCap":3975863197},{"date":"2022-12-02","current":-2.643918,"twenty":-4.161664,"median":-2.86319,"eighty":-2.462906,"marketCap":4420662516},{"date":"2022-12-09","current":-3.149151,"twenty":-4.107273,"median":-2.864198,"eighty":-2.475622,"marketCap":5314327445},{"date":"2022-12-16","current":-3.305139,"twenty":-4.051044,"median":-2.882842,"eighty":-2.478576,"marketCap":5564553626},{"date":"2022-12-23","current":-3.381937,"twenty":-4.04043,"median":-2.894354,"eighty":-2.482013,"marketCap":5695624482},{"date":"2022-12-30","current":-3.236489,"twenty":-4.017352,"median":-2.91136,"eighty":-2.482344,"marketCap":5516891496},{"date":"2023-01-06","current":-3.391948,"twenty":-4.007837,"median":-2.931792,"eighty":-2.484335,"marketCap":5841286276},{"date":"2023-01-13","current":-3.599992,"twenty":-3.997899,"median":-3.028307,"eighty":-2.489094,"marketCap":6318125972},{"date":"2023-01-20","current":-3.274887,"twenty":-3.960351,"median":-3.067138,"eighty":-2.491753,"marketCap":5698234367},{"date":"2023-01-27","current":-3.233118,"twenty":-3.939197,"median":-3.097872,"eighty":-2.491968,"marketCap":5626708412},{"date":"2023-02-03","current":-3.69441,"twenty":-3.928643,"median":-3.149151,"eighty":-2.494486,"marketCap":6462803880},{"date":"2023-02-10","current":-2.982995,"twenty":-3.919438,"median":-3.165799,"eighty":-2.508719,"marketCap":5186936694},{"date":"2023-02-17","current":-2.929036,"twenty":-3.863307,"median":-3.125282,"eighty":-2.512289,"marketCap":5044936998},{"date":"2023-02-24","current":-2.815147,"twenty":-3.837797,"median":-3.067138,"eighty":-2.524925,"marketCap":4789497150},{"date":"2023-03-03","current":-3.177519,"twenty":-3.836172,"median":-3.062189,"eighty":-2.525861,"marketCap":5440868762},{"date":"2023-03-10","current":-2.780338,"twenty":-2.887457,"median":-2.862997,"eighty":-2.813402,"marketCap":4725637188},{"date":"2023-03-17","current":-2.887659,"twenty":-6.745058,"median":-4.593114,"eighty":-3.296279,"marketCap":4955533051},{"date":"2023-03-24","current":-2.612069,"twenty":-6.736768,"median":-4.588347,"eighty":-3.266896,"marketCap":4534057302},{"date":"2023-03-31","current":-2.632175,"twenty":-6.734568,"median":-4.584133,"eighty":-3.247746,"marketCap":4534057302},{"date":"2023-04-06","current":-2.745164,"twenty":-6.732299,"median":-4.58201,"eighty":-3.245554,"marketCap":4725637188},{"date":"2023-04-14","current":-2.905521,"twenty":-6.72346,"median":-4.55657,"eighty":-3.235845,"marketCap":5006621020},{"date":"2023-04-21","current":-2.588135,"twenty":-6.708866,"median":-4.546798,"eighty":-3.196989,"marketCap":4457425347},{"date":"2023-04-28","current":-4.143444,"twenty":-6.693682,"median":-4.538595,"eighty":-3.180289,"marketCap":4240301476},{"date":"2023-05-05","current":-3.999602,"twenty":-6.69064,"median":-4.52917,"eighty":-3.191368,"marketCap":4099809560},{"date":"2023-05-12","current":-3.806764,"twenty":-6.679014,"median":-4.522481,"eighty":-3.196275,"marketCap":3875269876},{"date":"2023-05-19","current":-3.771563,"twenty":-6.673396,"median":-4.514341,"eighty":-3.199843,"marketCap":3785445740},{"date":"2023-05-25","current":-3.684445,"twenty":-6.661445,"median":-4.512446,"eighty":-3.226463,"marketCap":3682789585},{"date":"2023-06-02","current":-3.632573,"twenty":-6.658053,"median":-4.486619,"eighty":-3.234956,"marketCap":3618629487},{"date":"2023-06-09","current":-3.392773,"twenty":-6.652326,"median":-4.462291,"eighty":-3.236274,"marketCap":3374873717},{"date":"2023-06-16","current":-3.564649,"twenty":-6.635685,"median":-4.45465,"eighty":-3.234956,"marketCap":3528860351},{"date":"2023-06-23","current":-3.010726,"twenty":-6.610775,"median":-4.450713,"eighty":-3.234497,"marketCap":2964242695},{"date":"2023-06-30","current":-3.274952,"twenty":-6.583541,"median":-4.44228,"eighty":-3.234497,"marketCap":3195222645},{"date":"2023-07-07","current":-3.189107,"twenty":-6.573211,"median":-4.4415,"eighty":-3.21706,"marketCap":3105397109},{"date":"2023-07-14","current":-3.365903,"twenty":-6.569768,"median":-4.430064,"eighty":-3.234037,"marketCap":3323544840},{"date":"2023-07-21","current":-3.120491,"twenty":-6.567361,"median":-4.417451,"eighty":-3.210165,"marketCap":3066900450},{"date":"2023-07-28","current":-3.346032,"twenty":-6.564413,"median":-4.408129,"eighty":-3.196989,"marketCap":3285048181},{"date":"2023-08-04","current":-3.027308,"twenty":-6.564342,"median":-4.399316,"eighty":-3.194165,"marketCap":2977074914},{"date":"2023-08-11","current":-2.782359,"twenty":-6.564014,"median":-4.396571,"eighty":-3.189107,"marketCap":2720740259},{"date":"2023-08-18","current":-3.530437,"twenty":-6.55969,"median":-4.392518,"eighty":-3.172846,"marketCap":2849077064},{"date":"2023-08-25","current":-3.655856,"twenty":-6.554405,"median":-4.381873,"eighty":-3.176536,"marketCap":2951746508},{"date":"2023-09-01","current":-3.530032,"twenty":-6.533968,"median":-4.371418,"eighty":-3.184472,"marketCap":2861990034},{"date":"2023-09-08","current":-3.411902,"twenty":-6.518159,"median":-4.359552,"eighty":-3.189107,"marketCap":2733649674},{"date":"2023-09-15","current":-3.09954,"twenty":-6.509248,"median":-4.356975,"eighty":-3.184472,"marketCap":2502637025},{"date":"2023-09-22","current":-3.081221,"twenty":-6.493183,"median":-4.345154,"eighty":-3.172846,"marketCap":2476968953},{"date":"2023-09-29","current":-2.926752,"twenty":-6.480354,"median":-4.336586,"eighty":-3.159724,"marketCap":2356828062},{"date":"2023-10-06","current":-2.754135,"twenty":-6.470259,"median":-4.332194,"eighty":-3.149993,"marketCap":2216761940},{"date":"2023-10-13","current":-3.075296,"twenty":-6.459774,"median":-4.326035,"eighty":-3.128987,"marketCap":2471562163},{"date":"2023-10-20","current":-2.889523,"twenty":-6.458144,"median":-4.318868,"eighty":-3.124306,"marketCap":2318682029},{"date":"2023-10-27","current":-3.129013,"twenty":-6.456543,"median":-4.317435,"eighty":-3.120688,"marketCap":2509782196},{"date":"2023-11-03","current":-3.405912,"twenty":-6.449456,"median":-4.315677,"eighty":-3.121913,"marketCap":2739136797},{"date":"2023-11-10","current":-3.707675,"twenty":-6.422586,"median":-4.311136,"eighty":-3.12398,"marketCap":2981200049},{"date":"2023-11-17","current":-3.643128,"twenty":-6.418119,"median":-4.306778,"eighty":-3.125305,"marketCap":2955719706},{"date":"2023-11-24","current":-3.862579,"twenty":-6.411963,"median":-4.304547,"eighty":-3.125437,"marketCap":3159562445},{"date":"2023-12-01","current":-3.443396,"twenty":-6.402415,"median":-4.299316,"eighty":-3.125763,"marketCap":2828353515},{"date":"2023-12-08","current":-3.70655,"twenty":-6.380708,"median":-4.294096,"eighty":-3.126978,"marketCap":3032198813},{"date":"2023-12-15","current":-3.933018,"twenty":-6.355629,"median":-4.286687,"eighty":-3.129763,"marketCap":3236044112},{"date":"2023-12-22","current":-3.362344,"twenty":-6.341861,"median":-4.283518,"eighty":-3.135873,"marketCap":2764651859},{"date":"2023-12-29","current":-3.498637,"twenty":-6.326391,"median":-4.279732,"eighty":-3.145199,"marketCap":2892055171},{"date":"2024-01-05","current":-3.352806,"twenty":-6.311476,"median":-4.275394,"eighty":-3.148813,"marketCap":2751961912},{"date":"2024-01-12","current":-3.319994,"twenty":-6.301095,"median":-4.271829,"eighty":-3.150414,"marketCap":2726480783},{"date":"2024-01-19","current":-2.920642,"twenty":-6.289048,"median":-4.265098,"eighty":-3.14209,"marketCap":2395226109},{"date":"2024-01-26","current":-2.776093,"twenty":-6.275971,"median":-4.258402,"eighty":-3.125512,"marketCap":2267820464},{"date":"2024-02-02","current":-2.436086,"twenty":-6.260618,"median":-4.252597,"eighty":-3.121083,"marketCap":1987528047},{"date":"2024-02-09","current":-2.501845,"twenty":-6.25276,"median":-4.24782,"eighty":-3.105335,"marketCap":2051230870},{"date":"2024-02-16","current":-2.392552,"twenty":-6.251579,"median":-4.245111,"eighty":-3.084885,"marketCap":1962046919},{"date":"2024-02-23","current":-2.51456,"twenty":-6.247289,"median":-4.239252,"eighty":-3.064189,"marketCap":2051230870},{"date":"2024-03-01","current":-2.310081,"twenty":-6.222174,"median":-4.222385,"eighty":-3.040692,"marketCap":1885603532},{"date":"2024-03-08","current":-1.404154,"twenty":-6.191591,"median":-4.219168,"eighty":-3.008293,"marketCap":1146650796},{"date":"2024-03-15","current":-1.639631,"twenty":-6.153575,"median":-4.207661,"eighty":-2.990736,"marketCap":1337759263},{"date":"2024-03-22","current":-1.469204,"twenty":-6.137344,"median":-4.193365,"eighty":-2.948454,"marketCap":1197613054},{"date":"2024-03-28","current":-1.473918,"twenty":-6.118661,"median":-4.179198,"eighty":-2.936832,"marketCap":1197613054},{"date":"2024-04-05","current":-1.380747,"twenty":-6.07926,"median":-4.170971,"eighty":-2.929036,"marketCap":1121169668},{"date":"2024-04-12","current":-1.34863,"twenty":-6.060479,"median":-4.143701,"eighty":-2.916836,"marketCap":1095711942},{"date":"2024-04-19","current":-1.334087,"twenty":-6.029373,"median":-4.129341,"eighty":-2.905689,"marketCap":1082971105},{"date":"2024-04-26","current":-2.889721,"twenty":-6.019873,"median":-4.121148,"eighty":-2.897368,"marketCap":1146675288},{"date":"2024-05-03","current":-3.534325,"twenty":-5.992843,"median":-4.105499,"eighty":-2.894248,"marketCap":1401492019},{"date":"2024-05-10","current":-3.465269,"twenty":-5.966361,"median":-4.068484,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-05-17","current":-4.209422,"twenty":-5.951813,"median":-4.055358,"eighty":-2.894248,"marketCap":1670700543},{"date":"2024-05-24","current":-4.186851,"twenty":-5.939876,"median":-4.055358,"eighty":-2.894248,"marketCap":1657947103},{"date":"2024-05-31","current":-3.732161,"twenty":-5.929989,"median":-4.038887,"eighty":-2.894248,"marketCap":1479398954},{"date":"2024-06-07","current":-3.76901,"twenty":-5.876484,"median":-4.028312,"eighty":-2.894248,"marketCap":1492152393},{"date":"2024-06-14","current":-3.482276,"twenty":-5.858022,"median":-3.999602,"eighty":-2.894248,"marketCap":1377371440},{"date":"2024-06-21","current":-3.521893,"twenty":-5.826591,"median":-3.984491,"eighty":-2.894248,"marketCap":1390124879},{"date":"2024-06-28","current":-3.684975,"twenty":-5.785726,"median":-3.960681,"eighty":-2.894248,"marketCap":1453892075},{"date":"2024-07-05","current":-3.976759,"twenty":-5.708926,"median":-3.94724,"eighty":-2.894248,"marketCap":1568673028},{"date":"2024-07-12","current":-3.809506,"twenty":-5.666111,"median":-3.939197,"eighty":-2.894248,"marketCap":1504905832},{"date":"2024-07-19","current":-3.938567,"twenty":-5.64627,"median":-3.936259,"eighty":-2.894248,"marketCap":1555919589},{"date":"2024-07-26","current":-3.859662,"twenty":-5.597338,"median":-3.926532,"eighty":-2.894248,"marketCap":1530412711},{"date":"2024-08-02","current":-4.119373,"twenty":-5.565391,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-09","current":-3.996192,"twenty":-5.542318,"median":-3.926532,"eighty":-2.894248,"marketCap":1594179907},{"date":"2024-08-16","current":-4.218339,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1683453982},{"date":"2024-08-23","current":-4.073295,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1632440225},{"date":"2024-08-30","current":-4.899612,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1976783085},{"date":"2024-09-06","current":-4.739277,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1913015889},{"date":"2024-09-13","current":-4.720038,"twenty":-5.531989,"median":-3.926532,"eighty":-2.894248,"marketCap":1900262449},{"date":"2024-09-20","current":-4.628923,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":1874755571},{"date":"2024-09-27","current":-5.446446,"twenty":-5.53413,"median":-3.925687,"eighty":-2.894194,"marketCap":2219126271},{"date":"2024-10-04","current":-15.755499,"twenty":-5.548662,"median":-3.925687,"eighty":-2.894194,"marketCap":2476357202},{"date":"2024-10-10","current":-14.135917,"twenty":-5.573446,"median":-3.926532,"eighty":-2.894248,"marketCap":2208297918},{"date":"2024-10-18","current":-14.462213,"twenty":-5.610768,"median":-3.925687,"eighty":-2.894194,"marketCap":2246592101},{"date":"2024-10-25","current":-17.175371,"twenty":-5.653982,"median":-3.925687,"eighty":-2.894194,"marketCap":2667890820},{"date":"2024-11-01","current":-17.245924,"twenty":-5.680834,"median":-3.925687,"eighty":-2.894194,"marketCap":2680655848},{"date":"2024-11-08","current":-16.219086,"twenty":-5.78614,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-15","current":-15.508794,"twenty":-5.827373,"median":-3.925687,"eighty":-2.894194,"marketCap":2374295180},{"date":"2024-11-22","current":-16.352011,"twenty":-5.9148,"median":-3.925687,"eighty":-2.894194,"marketCap":2501945458},{"date":"2024-11-29","current":-17.863888,"twenty":-5.953064,"median":-3.925687,"eighty":-2.894194,"marketCap":2731715959},{"date":"2024-12-06","current":-18.910143,"twenty":-5.976081,"median":-3.925687,"eighty":-2.894194,"marketCap":2884896294},{"date":"2024-12-13","current":-22.026126,"twenty":-6.008757,"median":-3.925687,"eighty":-2.894194,"marketCap":3357202324},{"date":"2024-12-20","current":-19.368719,"twenty":-6.038268,"median":-3.925687,"eighty":-2.894194,"marketCap":2935956405},{"date":"2024-12-27","current":-19.29948,"twenty":-6.089632,"median":-3.925687,"eighty":-2.894194,"marketCap":2923191377},{"date":"2025-01-03","current":-20.796109,"twenty":-6.174931,"median":-3.925687,"eighty":-2.894194,"marketCap":3152961878},{"date":"2025-01-10","current":-18.25524,"twenty":-6.25082,"median":-3.925687,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-17","current":-18.24052,"twenty":-6.445489,"median":-3.927588,"eighty":-2.894194,"marketCap":2757246015},{"date":"2025-01-24","current":-20.141042,"twenty":-6.555254,"median":-3.927588,"eighty":-2.894194,"marketCap":3063606684},{"date":"2025-01-28","current":-19.53514,"twenty":-6.564014,"median":-3.928643,"eighty":-2.894248,"marketCap":2987016516},{"date":"2025-02-07","current":-19.814213,"twenty":-6.620453,"median":-3.926532,"eighty":-2.894141,"marketCap":3012546572},{"date":"2025-02-14","current":-22.723068,"twenty":-6.67789,"median":-3.926532,"eighty":-2.894141,"marketCap":3446557519},{"date":"2025-02-21","current":-26.033767,"twenty":-6.7434,"median":-3.926532,"eighty":-2.894141,"marketCap":3970369498},{"date":"2025-02-28","current":-28.807424,"twenty":-6.911713,"median":-3.926532,"eighty":-2.894141,"marketCap":4378896263},{"date":"2025-03-07","current":-28.524923,"twenty":-6.9876,"median":-3.922985,"eighty":-2.894088,"marketCap":4353363340},{"date":"2025-03-14","current":-30.855919,"twenty":-7.094956,"median":-3.927588,"eighty":-2.894088,"marketCap":4710824260},{"date":"2025-03-21","current":-29.696894,"twenty":-7.19083,"median":-3.938173,"eighty":-2.894088,"marketCap":4532093800},{"date":"2025-03-28","current":-44.206211,"twenty":-7.281486,"median":-3.953184,"eighty":-2.894088,"marketCap":4315063956},{"date":"2025-04-03","current":-40.26858,"twenty":-7.377266,"median":-3.972131,"eighty":-2.894088,"marketCap":3932070114},{"date":"2025-04-11","current":-31.529554,"twenty":-7.521044,"median":-3.977907,"eighty":-2.894088,"marketCap":3051184276},{"date":"2025-04-17","current":-35.141039,"twenty":-7.612577,"median":-3.984806,"eighty":-2.894141,"marketCap":3405181813},{"date":"2025-04-25","current":-39.824039,"twenty":-7.830066,"median":-3.999602,"eighty":-2.893971,"marketCap":3866441501},{"date":"2025-05-02","current":-40.436758,"twenty":-7.971418,"median":-4.00659,"eighty":-2.894088,"marketCap":3934273808},{"date":"2025-05-09","current":-37.951173,"twenty":-8.125706,"median":-4.030136,"eighty":-2.904367,"marketCap":3718361371},{"date":"2025-05-16","current":-39.292255,"twenty":-8.402557,"median":-4.054969,"eighty":-2.909393,"marketCap":3881209314},{"date":"2025-05-23","current":-48.489427,"twenty":-8.76248,"median":-4.07123,"eighty":-2.912068,"marketCap":4804014326},{"date":"2025-05-30","current":-54.004979,"twenty":-8.882707,"median":-4.108578,"eighty":-2.920581,"marketCap":5373982128},{"date":"2025-06-06","current":-53.187404,"twenty":-9.067711,"median":-4.134025,"eighty":-2.920581,"marketCap":5306128818},{"date":"2025-06-13","current":-62.277497,"twenty":-9.366509,"median":-4.171793,"eighty":-2.920581,"marketCap":6215439503},{"date":"2025-06-20","current":-55.860088,"twenty":-9.719391,"median":-4.1939,"eighty":-2.920581,"marketCap":5564039730},{"date":"2025-06-27","current":-57.470323,"twenty":-9.919518,"median":-4.210698,"eighty":-2.920642,"marketCap":5740460502},{"date":"2025-07-04","current":-70.509918,"twenty":-9.96315,"median":-4.214054,"eighty":-2.920642,"marketCap":7043260048},{"date":"2025-07-11","current":-72.89851,"twenty":-10.187483,"median":-4.217237,"eighty":-2.920642,"marketCap":7274522110},{"date":"2025-07-18","current":-96.028249,"twenty":-10.444237,"median":-4.259839,"eighty":-2.920642,"marketCap":9575122927},{"date":"2025-07-25","current":-109.369715,"twenty":-10.675922,"median":-4.302518,"eighty":-2.920642,"marketCap":10945079632},{"date":"2025-08-01","current":-98.766317,"twenty":-11.028128,"median":-4.334288,"eighty":-2.920642,"marketCap":9822881055},{"date":"2025-08-08","current":-102.320343,"twenty":-11.210508,"median":-4.343155,"eighty":-2.920642,"marketCap":10201805250},{"date":"2025-08-15","current":-136.537801,"twenty":-11.629311,"median":-4.351854,"eighty":-2.920642,"marketCap":13593043587},{"date":"2025-08-22","current":-34.413615,"twenty":-11.870503,"median":-4.358449,"eighty":-2.920642,"marketCap":14120359933},{"date":"2025-08-29","current":-38.22937,"twenty":-12.785549,"median":-4.358449,"eighty":-2.920642,"marketCap":15760899677},{"date":"2025-09-05","current":-43.631932,"twenty":-13.262082,"median":-4.358449,"eighty":-2.920642,"marketCap":17970398621},{"date":"2025-09-12","current":-35.323219,"twenty":-13.467457,"median":-4.378646,"eighty":-2.920642,"marketCap":14574532540},{"date":"2025-09-19","current":-30.095318,"twenty":-13.678999,"median":-4.405143,"eighty":-2.920642,"marketCap":12408662899},{"date":"2025-09-26","current":-26.446279,"twenty":-14.059898,"median":-4.4171,"eighty":-2.920642,"marketCap":10875828070},{"date":"2025-10-03","current":-28.012348,"twenty":-14.148515,"median":-4.421903,"eighty":-2.921048,"marketCap":11547355709},{"date":"2025-10-10","current":-24.116553,"twenty":-14.462213,"median":-4.4171,"eighty":-2.920642,"marketCap":9926930319},{"date":"2025-10-17","current":-24.725072,"twenty":-15.180426,"median":-4.4171,"eighty":-2.920642,"marketCap":10169487889},{"date":"2025-10-24","current":-22.615857,"twenty":-15.755499,"median":-4.4171,"eighty":-2.920642,"marketCap":9305344739},{"date":"2025-10-31","current":-22.367787,"twenty":-16.219086,"median":-4.4171,"eighty":-2.920642,"marketCap":9217002859},{"date":"2025-11-07","current":-19.414218,"twenty":-16.550087,"median":-4.4171,"eighty":-2.920642,"marketCap":7994940179},{"date":"2025-11-14","current":-21.676779,"twenty":-16.716727,"median":-4.4171,"eighty":-2.920642,"marketCap":8951977217},{"date":"2025-11-21","current":-19.867752,"twenty":-17.175371,"median":-4.4171,"eighty":-2.920642,"marketCap":8201071234},{"date":"2025-11-28","current":-21.715013,"twenty":-17.817357,"median":-4.4171,"eighty":-2.920642,"marketCap":8996148158},{"date":"2025-12-05","current":-20.116662,"twenty":-18.156074,"median":-4.4171,"eighty":-2.920642,"marketCap":8348307701},{"date":"2025-12-12","current":-21.673135,"twenty":-18.597879,"median":-4.4171,"eighty":-2.920642,"marketCap":9010871804},{"date":"2025-12-19","current":-21.268873,"twenty":-18.932983,"median":-4.4171,"eighty":-2.920642,"marketCap":8863635337},{"date":"2025-12-24","current":-19.934886,"twenty":-19.027132,"median":-4.4171,"eighty":-2.920642,"marketCap":8333584054},{"date":"2026-01-02","current":-18.734094,"twenty":-19.229249,"median":-4.412297,"eighty":-2.920581,"marketCap":7862427359},{"date":"2026-01-09","current":-20.262357,"twenty":-19.347505,"median":-4.412297,"eighty":-2.920581,"marketCap":8524991462},{"date":"2026-01-16","current":-21.312952,"twenty":-19.438402,"median":-4.412297,"eighty":-2.920581,"marketCap":8996148158},{"date":"2026-01-23","current":-19.727354,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":8318882544},{"date":"2026-01-30","current":-18.664391,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7906619339},{"date":"2026-02-06","current":-17.611774,"twenty":-19.550014,"median":-4.412297,"eighty":-2.920581,"marketCap":7479632447},{"date":"2026-02-13","current":-20.40709,"twenty":-19.573276,"median":-4.4171,"eighty":-2.920642,"marketCap":8716570064},{"date":"2026-02-20","current":-21.334077,"twenty":-19.730666,"median":-4.385799,"eighty":-2.920519,"marketCap":9099392398},{"date":"2026-02-27","current":-22.809976,"twenty":-19.827105,"median":-4.385799,"eighty":-2.920519,"marketCap":9835589194},{"date":"2026-03-06","current":-22.892085,"twenty":-19.876517,"median":-4.385799,"eighty":-2.920519,"marketCap":9791417386},{"date":"2026-03-13","current":-24.363526,"twenty":-19.939651,"median":-4.385799,"eighty":-2.920519,"marketCap":10468779101},{"date":"2026-03-20","current":-23.561814,"twenty":-20.090468,"median":-4.385799,"eighty":-2.920519,"marketCap":10085954549},{"date":"2026-03-27","current":-24.787283,"twenty":-20.254301,"median":-4.385799,"eighty":-2.920519,"marketCap":12265109692},{"date":"2026-04-02","current":-27.689391,"twenty":-20.348654,"median":-4.385799,"eighty":-2.920519,"marketCap":13766959859},{"date":"2026-04-10","current":-29.593377,"twenty":-20.420045,"median":-4.385799,"eighty":-2.920519,"marketCap":14827089388},{"date":"2026-04-17","current":-29.673335,"twenty":-20.493961,"median":-4.385799,"eighty":-2.920519,"marketCap":14873393340},{"date":"2026-04-24","current":-30.832617,"twenty":-20.822018,"median":-4.385799,"eighty":-2.920519,"marketCap":15455344849},{"date":"2026-04-30","current":-29.603766,"twenty":-21.040655,"median":-4.385799,"eighty":-2.920519,"marketCap":14848626766},{"date":"2026-05-08","current":-26.809523,"twenty":-21.31078,"median":-4.359302,"eighty":-2.920458,"marketCap":13488807400},{"date":"2026-05-15","current":-25.630341,"twenty":-21.467249,"median":-4.359302,"eighty":-2.920458,"marketCap":12929437425},{"date":"2026-05-22","current":-25.466772,"twenty":-21.685779,"median":-4.385799,"eighty":-2.920519,"marketCap":12817563430},{"date":"2026-05-29","current":-25.473606,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":12865585130},{"date":"2026-06-05","current":-14.851235,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7511583865},{"date":"2026-06-12","current":-14.766427,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7463637585},{"date":"2026-06-18","current":-14.604908,"twenty":-21.880534,"median":-4.385799,"eighty":-2.920519,"marketCap":7399709211},{"date":"2026-06-26","current":-13.979206,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7048103158},{"date":"2026-07-03","current":-17.167949,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":8662294584},{"date":"2026-07-10","current":-16.745047,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":8438545278},{"date":"2026-07-17","current":-14.315543,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7239888278},{"date":"2026-07-24","current":-14.596678,"twenty":-21.884806,"median":-4.359302,"eighty":-2.920458,"marketCap":7383727118},{"date":"2026-07-31","current":-13.622962,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":6904264318},{"date":"2026-08-07","current":-16.539337,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":8398590044},{"date":"2026-08-14","current":-18.058677,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9181712618},{"date":"2026-08-21","current":-16.885224,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":8604057841},{"date":"2026-08-28","current":-19.208873,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9389321617},{"date":"2026-08-31","current":-18.760275,"twenty":-21.889079,"median":-4.358449,"eighty":-2.920396,"marketCap":9166145891}],"updateTime":1788262848511},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02616\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623377669","title":"A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2623377669","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623377669?lang=en_us&edition=fundamental","pubTime":"2026-03-31 10:07","pubTimestamp":1774922859,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (SEHK:2616) has drawn fresh attention after reporting detailed Phase I/II data for CS2009, its trispecific antibody, alongside full year 2025 results that show CNY 269.58 million in sales and a CNY 437 million net loss.\nSee our latest analysis for CStone Pharmaceuticals.\nThe encouraging CS2009 data appears to be feeding into a strong shift in sentiment, with a 1 day share price return of 5.04% and a 7 day share price return of 40.68% at HK$8.75. Momentum has been...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/a-look-at-cstone-pharmaceuticals-sehk2616-valuation-after-en","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2616/cstone-pharmaceuticals-shares/news/a-look-at-cstone-pharmaceuticals-sehk2616-valuation-after-en","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190381168","title":"Stock Track | CStone Pharma-B Soars 5.04% Intraday on Bullish Analyst Reports and Positive CS2009 Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1190381168","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190381168?lang=en_us&edition=fundamental","pubTime":"2026-03-30 13:36","pubTimestamp":1774848996,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals' stock surged 5.04% during the intraday session, following the release of highly positive research reports from two major international investment banks.Jefferies maintained...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173745104","title":"Two Major Foreign Institutions Bullish on CStone Pharma: Peak Target Price Set at HK$20, CS2009 Emerges as Key Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1173745104","media":"Stock News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173745104?lang=en_us&edition=fundamental","pubTime":"2026-03-30 09:26","pubTimestamp":1774833998,"startTime":"0","endTime":"0","summary":"Recent research reports from multiple international investment firms have expressed positive views on the clinical data and commercial prospects of CStone Pharmaceuticals' core investigational...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622181426","title":"CStone Pharmaceuticals' Loss Widens in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2622181426","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622181426?lang=en_us&edition=fundamental","pubTime":"2026-03-27 12:30","pubTimestamp":1774585858,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals  booked a loss of 437 million yuan in 2025, widening from 91.2 million yuan a year earlier, according to a Thursday Hong Kong bourse filing.Shares of the pharmaceutical firm were up nearly 18% in late Friday morning trade.Loss per share came in at 0.31 yuan, compared with 0.07 yuan a year earlier.Revenue fell 34% to 269.6 million yuan from 407.2 million yuan.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135867297","title":"CStone Pharmaceuticals-B Surges Over 20% by Late Morning on Strong CS2009 Lung Cancer Efficacy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1135867297","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135867297?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:50","pubTimestamp":1774583426,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) saw its gains expand to over 20% by late morning. At the time of writing, the stock was up 20.29%, trading at HK$8.30, with a turnover of HK$390 million. The company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02616","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184614767","title":"CSTONE PHARMA-B (02616) Surges Over 20% on Strong CS2009 Lung Cancer Efficacy Data; First Phase III Global Trials Expected This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1184614767","media":"Stock News","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184614767?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:32","pubTimestamp":1774582341,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) saw its gains expand beyond 20%. At the time of writing, the stock was up 19.42% to HK$8.24, with a turnover of HK$377 million. The surge follows the company's announcement of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","02616","BK4134","BK4585","BK4588","VXUS","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134940401","title":"Stock Track | CStone Pharma Soars 5.51% Intraday on Strong 2025 Results and Promising Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1134940401","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134940401?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:39","pubTimestamp":1774575550,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals' stock surged 5.51% during intraday trading on Friday, following the release of its 2025 annual results which highlighted significant strategic and clinical advancements.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622247863","title":"Press Release: CStone Announces 2025 Annual Results: Accelerated Expansion of Global Commercial Footprint and Efficient Advancement of Innovation Pipeline 2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2622247863","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622247863?lang=en_us&edition=fundamental","pubTime":"2026-03-26 21:32","pubTimestamp":1774531920,"startTime":"0","endTime":"0","summary":"-- The global, multicenter Phase I/II clinical trial of CS2009. Australia and China, and the Phase II IND application has been approved. in the US. CS2009 demonstrates an excellent safety profile with a >=Grade. 3 TRAE rate of 23%, along with broad-spectrum anti-tumor activity.Notably, monotherapy data in lung cancer are encouraging: in first-line. NSCLC patients with PD-L1 TPS >=50%, the ORR reached 90% with a DCR of. 100%, while the ORR was 25% in IO-pretreated NSCLC .Furthermore, significant benefits were observed in patients with heavily. pre-treated \"cold tumors,\" achieving an ORR of 40% in non-clear cell. renal cell carcinoma  and 33.3% in soft tissue sarcoma .-- The global Phase Ib multicenter trial of CS5001  is being. advanced rapidly and efficiently in Australia and China, with its R&D. progress ranking among the top two globally. In combination with R-CHOP. rate exceeds 90%, and the ORR reaches 100%. Additionally, the combination. complementing its successful NRDL renewal at","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2487616109.SGD","LU1093756168.USD","LU0053666078.USD","BK1161","02616","BK1574","BK4218","BK4588","IE00BYQQ9H92.USD","HCC","LU0456854461.SGD","BK4181","LU2211817866.USD","BK4107","IE00B5TLWC47.USD","LU1169589451.USD","R","CC","BK4022","LU0210528500.USD","BK4533","LU0347712357.USD","BK4007","LU1721428933.USD","BK4098","IE00BFXG0V08.USD","BK4548","L","LU1169590202.USD","MTD","BK4121","BK4023","BK4156","LU1093756325.SGD","BK4232","CRC","LU2413666426.HKD","LU2413666699.HKD","ORR","PD","BK4006","BK4567","LU0266512127.USD","PROC","PK","BK4213","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850657","title":"CStone Pharmaceuticals -  Loss for the Year Was RMB437.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850657?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:43","pubTimestamp":1774529020,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E0JB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850658","title":"CStone Pharmaceuticals FY2025; revenue drops 33.8% to RMB 270 million due to lower licensing fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850658?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:43","pubTimestamp":1774529009,"startTime":"0","endTime":"0","summary":"CStone reported expanded international regulatory approvals for sugemalimab in the EU and the UK, adding an additional indication in III-stage NSCLC.The company also signed commercialization agreements for sugemalimab covering 10 Latin American countries and 23 Western European countries plus the UK.CStone said it has established partnerships that extend sugemalimab’s international reach to more than 60 countries.In China, pralsetinib was added to the national reimbursement drug list effective January 1, 2026, which the company expects to support future demand.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CStone Pharmaceuticals published the original content used to generate this news brief via IIS, the Issuer Information Service ope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL24Pm23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104410716","title":"CStone reports 90% ORR in first-line NSCLC for trispecific antibody CS2009; Phase III global trials slated for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1104410716","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104410716?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:23","pubTimestamp":1774517028,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (CStone) released a voluntary update on the clinical progress of its self-developed trispecific antibody CS2009 (PD-1/VEGF/CTLA-4), highlighting an improved safety profile,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189079157","title":"CStone Pharmaceuticals-B Unveils Latest Clinical Progress and Phase I/II Key Data for Trispecific Antibody CS2009","url":"https://stock-news.laohu8.com/highlight/detail?id=1189079157","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189079157?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:21","pubTimestamp":1774516865,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) has announced the latest clinical progress for its internally developed PD-1/VEGF/CTLA-4 trispecific antibody, CS2009. The data demonstrate an excellent safety...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","LU1169589451.USD","LU1169590202.USD","BK1161","02616","BK4023","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622307678","title":"CStone Pharmaceuticals reports CS2009 Phase I safety; Grade ≥3 TRAEs rise to 23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622307678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622307678?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:01","pubTimestamp":1774515690,"startTime":"0","endTime":"0","summary":"CStone reported updated Phase I/II clinical progress for CS2009, a PD-1/VEGF/CTLA-4 trispecific antibody, from ongoing trials in Australia and China.As of mid-March 2026, Phase I enrolled 113 patients with advanced solid tumors and reported a 23% incidence of Grade ≥3 treatment-related adverse events.In Phase II first-line NSCLC with PD-L1 TPS ≥50%, CS2009 monotherapy showed a 90% overall response rate and a 100% disease control rate.The company said updated Phase I and Phase II data are expected to be presented at the 2026 ASCO Annual Meeting and/or the 2026 ESMO Congress.CStone plans to initiate Phase III global multi-regional clinical trials for CS2009 by the end of 2026 in indications including NSCLC and colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL70Wbzt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622278830","title":"CStone Pharmaceuticals reports CS2009 Phase I/II progress; ORR rises to 90% in first-line NSCLC with PD-L1 TPS≥50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622278830","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622278830?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:01","pubTimestamp":1774515681,"startTime":"0","endTime":"0","summary":"CStone reported new development progress for CS2009, positioning the program as a potential differentiated entrant in immuno-oncology by combining multiple established targets into a single drug candidate.The company said it plans to start its first global Phase 3 multi-regional clinical trials by the end of 2026, initially targeting non-small cell lung cancer, colorectal cancer, and small cell lung cancer.CStone disclosed that 113 patients had been enrolled in the Phase 1 study as of mid-March 2026, supporting continued advancement of the asset into later-stage development.The company also said additional Phase 1 and Phase 2 data are expected to be presented in 2026 at major oncology conferences, which could influence partnering and competitive positioning.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL72mNTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163282057","title":"CSTONE PHARMA-B Shares Extend Gains Following Top ESMO Guideline Recommendation for Core Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1163282057","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163282057?lang=en_us&edition=fundamental","pubTime":"2026-03-26 10:58","pubTimestamp":1774493905,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) saw its shares rise more than 4% again. At the time of writing, the stock was up 3.77% to HK$7.14, with a turnover of HK$35.6465 million. The movement follows an announcement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1574","BK4588","BK4585","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172230908","title":"CStone Pharmaceuticals' Sugemalimab Receives ESMO Guideline Recommendation for Stage III NSCLC Consolidation Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1172230908","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172230908?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:24","pubTimestamp":1774430687,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) announced that its core commercial product, sugemalimab, has received a [I, A] grade recommendation in the European Society for Medical Oncology (ESMO) guidelines....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","BK1574","BK4134","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622029921","title":"CStone Pharmaceuticals’ sugemalimab gains ESMO I,A recommendation; consolidation treatment duration rises to 24 months for stage III NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2622029921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622029921?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:16","pubTimestamp":1774430181,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals’ sugemalimab gains ESMO I,A recommendation; consolidation treatment duration rises to 24 months for stage III NSCLC. Sugemalimab gained an ESMO guideline recommendation at level [I, A] for consolidation treatment in stage III non-small cell lung cancer, a milestone that could strengthen its positioning against established immuno-oncology options in Europe.The update adds Sugemalimab to ESMO’s “Early and Locally Advanced Non-Small-Cell Lung Cancer Living Guideline,” which may support market access momentum across the EU and other markets.ESMO’s recommendation specifies use for eligible stage III NSCLC patients after concurrent or sequential chemoradiotherapy, with treatment duration capped at no more than 24 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5g6JRt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02616","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152835973","title":"CSTONE PHARMA-B Shares Climb Over 4% on Triple Pipeline Recognition at Prestigious Cancer Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1152835973","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152835973?lang=en_us&edition=fundamental","pubTime":"2026-03-24 10:24","pubTimestamp":1774319068,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) rose more than 4%. At the time of writing, the stock was up 3.05%, trading at HK$6.41 with a turnover of HK$18.1843 million. The increase follows recent news that the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02616","BK4588","BK4585","VXUS","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172787493","title":"CSTONE PHARMA-B to Present Three Self-Developed Pipeline Findings at Prestigious Global Oncology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1172787493","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172787493?lang=en_us&edition=fundamental","pubTime":"2026-03-18 07:20","pubTimestamp":1773789619,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) announced that preclinical research findings from three of its internally developed drug pipelines have been selected for poster presentation at the 2026 American Association...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153215896","title":"CStone Pharma-B (02616 HK) to Showcase Three Novel ADC Candidates at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1153215896","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153215896?lang=en_us&edition=fundamental","pubTime":"2026-03-18 06:42","pubTimestamp":1773787345,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals (CStone Pharma-B, 02616 HK) announced that preclinical data for three proprietary antibody-drug conjugates (ADCs)—CS5007, CS5008 and CS5006—have been accepted for poster...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":144,"code":"91000000","status":"200"}]}}